Journal
EUROPEAN JOURNAL OF EPIDEMIOLOGY
Volume 35, Issue 7, Pages 619-630Publisher
SPRINGER
DOI: 10.1007/s10654-020-00636-1
Keywords
Clinical prediction model; Treatment; Censoring; Estimands; Predictimands
Categories
Funding
- Medical Research Council [MC_UU_12023/21, MC_UU_12023/29]
- MRC [MC_UU_12023/21] Funding Source: UKRI
Ask authors/readers for more resources
In this paper we study approaches for dealing with treatment when developing a clinical prediction model. Analogous to the estimand framework recently proposed by the European Medicines Agency for clinical trials, we propose a 'predictimand' framework of different questions that may be of interest when predicting risk in relation to treatment started after baseline. We provide a formal definition of the estimands matching these questions, give examples of settings in which each is useful and discuss appropriate estimators including their assumptions. We illustrate the impact of the predictimand choice in a dataset of patients with end-stage kidney disease. We argue that clearly defining the estimand is equally important in prediction research as in causal inference.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available